Dermoscopy Patterns of Halo Nevi (2024)

Abstract

Background Halo nevi (HN) are benign melanocytic nevi surrounded by a depigmented area (halo). This study aims to evaluate the dermoscopic features of HN and their changes during digital dermoscopic follow-up and to investigate the frequency of the halo phenomenon in a series of melanomas.

Observations In a retrospective study, digital dermoscopic images of HN from patients who attended the Pigmented Skin Lesions Clinic of the Department of Dermatology, Medical University of Graz, between October 1, 1997, and March 31, 2004, were reviewed and classified by dermoscopic morphologic criteria. For HN that were followed up with digital dermoscopy, the percentages of changes in the size of the nevus and halo components were calculated. In addition, digital dermoscopic images of histopathologically confirmed melanomas obtained from the same database were reviewed for the presence of an encircling halolike depigmentation. We classified 138 HN in 87 patients (mean age, 22.4 years). The most common dermoscopic structures were the globular and/or hom*ogeneous patterns in more than 80% of HN. Follow-up of 33 HN revealed considerable size reduction of the nevus component, but this was not associated with significant structural changes. Of a total of 475 melanomas, only 2 revealed an encircling halo, but both displayed clear-cut melanoma-specific patterns according to dermoscopy.

Conclusions Halo nevi exhibit the characteristic dermoscopic features of benign melanocytic nevi, represented by globular and/or hom*ogeneous patterns that are typically observed in children and young adults. Halo nevi reveal considerable changes of area over time during digital dermoscopic follow-up, albeit their structural patterns remain unchanged. For this reason and because melanoma with halolike depigmentation, despite being rare, additionally exhibits melanoma-specific dermoscopic criteria, the role of digital dermoscopic follow-up in the diagnosis of HN is insignificant.

Halo nevi (HN), also termed Sutton nevi or leukoderma acquisitum centrifugum, are defined as benign melanocytic nevi that are surrounded by a rim of depigmentation, resembling a halo.1-3 Halo nevi are common in children and young adults, with a mean age at onset of 15 years.4 Affected individuals frequently have multiple HN, which are usually localized on the back and may be clustered.4 The incidence of HN in the population is estimated to be approximately 1%.5 There is no predilection for sex, and all races are susceptible to the development of these lesions. A familial tendency for HN has been reported,5 and HN may be associated with atopic dermatitis or with autoimmune disorders such as vitiligo and Hashimoto thyroiditis.4-6

For a period of months or even years, HN tend to undergo 4 clinical stages characterized by a progressive involution with subsequent total regression of the central nevus. The underlying pathogenesis is not yet fully understood, but T lymphocytes are considered to play a key role in the progressive destruction of nevus cells.7-11 Although the halo phenomenon is most common in benign melanocytic nevi, reports of HN in individuals with a family and/or personal history of melanoma and melanomas with halo prompted concerns about the diagnosis and management of melanocytic skin lesions that exhibit an encircling halo.12-15

Dermoscopy gained popularity because it permits a more accurate diagnosis and management of melanocytic skin lesions compared with examination with the naked eye.16-19 Although the dermoscopic criteria of many benign melanocytic skin lesions and melanoma have been studied extensively, the dermoscopic structures that characterize HN have not yet been described in detail. We analyzed the dermoscopic structures in HN and correlated the dermoscopic findings with changes in the size of the nevus and halo components of HN over time. Moreover, we investigated the frequency of halo phenomenon in melanomas to evaluate the occurrence of this peculiar type of regression.

Methods

For this retrospective study, dermoscopic images of HN were selected from a database that contained 29383 digital images of pigmented skin lesions from 6079 patients who attended the Pigmented Skin Lesions Clinic of the Department of Dermatology, Medical University of Graz, between October 1, 1997, and March 31, 2004. The digital dermoscopic images were recorded with a digital epiluminescence microscopic system (Mole Max II; Derma Medical Systems, Vienna, Austria) and stored at 30-fold magnification in JPEG format, with a resolution of 640×480 pixels at 24-bit color depth. The diagnosis of HN was made by experienced dermatologists (I.K., A.D.S., and R.H.-W.) and was based on clinical and dermoscopic examination. The HN were classified according to the primary dermoscopic structural patterns (reticular, globular, or hom*ogeneous).18 When 2 different dermoscopic structural patterns were present, the HN were classified as reticular-globular, hom*ogeneous-globular, or hom*ogeneous-reticular. The HN that showed almost total disappearance of the nevus were classified as regressed. If a nevus could not be classified because of poor quality of the digital dermoscopic image, it was labeled as “not classifiable.”

When available, follow-up digital images of a given nevus were measured and compared with the earlier digital images. Because of the retrospective study design, we were unable to clarify the exact time of onset of HN in an individual patient. However, given that the approximate waiting time for consultation at our specialized clinic is 2 months, we assumed that the baseline visit for treatment of HN was sought within the first 3 months of onset. Measurement was performed onscreen (semiautomatically) with the Mole Max “Expertizer” program (Derma Medical Systems), and the percentage of change in the area per month was calculated for both the nevus and halo components. In addition, we reviewed the dermoscopic images of histopathologically confirmed melanomas obtained from the same database for the presence of an encircling halo.

Results

We analyzed 138 digital dermoscopic images of HN from 87 patients. Of the 138 HN, 123 (89.1%) were located on the trunk, 12 (8.7%) on upper or lower extremities, and 3 (2.2%) on the head and neck region (Figure 1). Forty-six patients (52.9%) were women and 41 (47.1%) were men, with a mean age for all patients of 22.4 years (range, 5-69 years).

Figure 1.

View LargeDownload

Geometric body site–related distribution of halo nevi (N=138).

From data included in the patient registration forms, we recorded concomitant diseases (Table 1). In 6 patients, generally accepted risk factors for melanoma were recorded. These patients were older (mean age, 34.8 years; range, 14-58 years) with respect to the mean age of 23.2 years in our study population. However, in none of these patients was the time at onset of HN related to melanoma development and/or melanoma progression.

Table 1.

View LargeDownload

Demographics of Patients With Halo Nevi Revealing a History of Concomitant Disease

In 58 nevi (42.0%), we observed a combination of hom*ogeneous and globular patterns in different areas of the lesion. The hom*ogeneous-globular pattern was followed in frequency by the hom*ogeneous pattern (32 nevi; 23.2%) and the globular pattern (24 nevi; 17.4%) (Figure 2 and Figure 3). Variations on the reticular patterns were recorded in only 9 nevi, and no single nevus in the study showed a combination of all 3 patterns (reticular, globular, and hom*ogeneous). Three nevi showed complete regression of the nevus component, characterized by a light brown to pink central area that exhibited dotted vessels as the only dermoscopic feature (Figure 4).

Figure 2.

View LargeDownload

Geometric distribution of dermoscopic morphologic patterns in 138 halo nevi.

Figure 3.

View LargeDownload

Dermoscopically, this nevus exhibits a globular pattern and an encircling rim of a white structureless area corresponding to the surrounding halo (hematoxylin-eosin, original magnification ×10).

Figure 4.

View LargeDownload

This completely regressed nevus reveals a central light brown to pink area with some dotted vessels as the only dermoscopic structure. In addition, telangiectases can be seen within the whitish halo and the normal skin (hematoxylin-eosin, original magnification ×10).

From a total of 138 HN, we were able to follow changes in 33 HN (23.9%) from 16 patients. The mean follow-up period for these nevi was 26 months (range, 4-61 months). We observed a reduction in the nevus area in all HN, with a mean reduction of 2.2% per month. For 12 HN a follow-up image was available within 6 months after the initial baseline visit, and these nevi showed a mean reduction in the nevus area of 5.2% per month during the first 6 months (Table 2).

Table 2.

View LargeDownload

Nevus Size at Baseline and During Follow-up of 33 Halo Nevi

Halo size decreased over time in 17 (51.5%) of the 33 cases for which follow-up images were available (Figure 5), with a mean reduction in the halo area of 0.85% per month. Nine (27.3%) of the 33 HN showed a considerable enlargement of the halo component, with a mean increase in size of 1.3% per month. Poor quality of the follow-up images or large size of the HN, extending beyond the maximum field of view of the image frame, precluded our measuring change in halo area for the remaining 7 HN (21.2%).

Figure 5.

View LargeDownload

Halo nevus on the back of a 20-year-old man. A, Dermoscopic image of the halo nevus shows the globular pattern (inset: clinical image). The area of the nevus is 8.1 mm2. B, Dermoscopic image of the same nevus 10 months later. The nevus still exhibits a globular pattern but the area is decreased to 6.1 mm2 (original magnification ×10 [A and B]).

Remarkably, of 475 melanomas, only 2 (0.4%) showed an encircling halo. The 2 melanomas were located on the backs of a 33-year-old man (patient 1) and a 44-year old man (patient 2). In the first case, histologic analysis revealed a superficial spreading melanoma with focal regression (Clark level III; tumor thickness, 1.25 mm with focal regression), whereas in the second case, an exact histopathologic measurement of the level of invasion and tumor thickness was not possible because of the presence of significant extensive regression. Dermoscopy of both melanomas revealed a multicomponent pattern, characterized by a marked asymmetry of structures (ie, atypical pigment network, blue-white veil, irregular dots and globules, streaks, and regression structures) and colors that varied from white to brown to blue to black (Figure 6).

Figure 6.

View LargeDownload

Dermoscopy of a halo melanoma located on the back of a 33-year-old man (patient 1). A multicomponent pattern is represented by a blue-white veil, irregular dots and globules, irregular streaks, atypical network, and regression structures showing linear-irregular vessels and blue to gray pepperlike granules (hematoxylin-eosin, original magnification ×10).

Comment

In our study, we found the globular and/or hom*ogeneous patterns to be the typical dermoscopic features in HN. These patterns are generally associated with benign melanocytic nevi and represent, together with the reticular patterns, the main criteria in the dermoscopic classification of melanocytic nevi.17,18 Notably, only a small proportion of HN in our series displayed reticular and/or unspecific patterns. The high frequency of globular and hom*ogeneous patterns compared with reticular patterns in our series of HN is an intriguing observation that requires further examination.

One explanation might be that halo phenomenon commonly occurs in melanocytic nevi, such as compound nevi, congenital melanocytic nevi, and less frequently, compound Spitz nevi and blue nevi.3-6,9,10 All these nevi are common in children and young adults and often exhibit globular and/or hom*ogeneous patterns according to dermoscopy, including the so-called cobblestone patterns as a variant of the globular patterns.17,18 We recently demonstrated that nevi exhibit considerable age-related differences in their dermoscopic patterns, with variations on the globular pattern as the characteristic feature of nevi in children and of the reticular patterns in adults.20 Given that a mean age of 22.4 years in the present study reflects a relatively young study population, it could therefore be assumed that the predominance of the globular and/or hom*ogeneous patterns in our series of HN was influenced by the age of our study population.

Only 6 patients had recorded risk factors for melanoma. These patients tended to be older at onset of HN compared with those without risk factors, although no significant differences in dermoscopic pattern of HN between these 2 patients groups were observed. In no patient was the onset of HN directly time related to melanoma development and/or progression. Accordingly, our data do not support previous reports that have suggested an association between HN and melanoma. However, following the general rule that the examination of all patients with pigmented skin tumors should include an inspection of the entire body, we consider the same procedure also valid for patients with HN, regardless of associated risk factors. On the other hand, the decision to perform a biopsy on a halo lesion that reveals clinically and/or dermoscopically atypical features must not be based on the patient's age.12-15

In addition, we analyzed follow-up images of 33 HN and compared these images with those obtained at the initial visit. Although we were unable to clarify the exact onset of HN development because of the retrospective study design, we observed in 12 HN a marked reduction in size of the nevus component during the first 6 months of the follow-up period, whereas changes in size were less evident after the first 6 months.

In this context it seems critical to underline that the primary purpose of short-term follow-up is to monitor eventual changes over time, which aids the more accurate differentiation of melanoma from nevi. It has been shown that significant changes in size, structure, and/or morphologic findings that occur in the short time of 3 to 6 months are often associated with melanoma, whereas such changes are unusual in benign nevi.21-25

Because we found remarkable changes in the size of HN during follow-up, albeit the dermoscopic patterns remained basically unchanged, our observation questions in part the value of short-term digital dermoscopic follow-up for the diagnosis of these particular nevi and the impact of follow-up on their differentiation from melanoma. This is also because we found that halo melanoma not only was rare (2 of 478 melanomas) but also revealed evident melanoma-specific patterns according to dermoscopy that allowed its diagnosis with high confidence and without the need for additional digital dermoscopic follow-up. Thus, the halo was more irregular than that seen in HN. Furthermore, both melanomas occurred in adults and exhibited a multicomponent pattern, including an atypical pigmented network, irregular dots and globules, irregular streaks, blotches, blue-white veil, and atypical vascular structures. These features are strongly associated with melanoma and therefore indicate the necessity of subsequent histopathologic diagnosis.17,26 Despite this finding, it must be noted that digital dermoscopic follow-up carries the certain risk that a lesion that displays extensive regression at baseline could eventually completely regress during follow-up and subsequently would no longer be detectable at the next visit. We therefore conclude that digital dermoscopic follow-up of HN does not provide additional diagnostic information compared with a good clinical dermoscopic correlation at baseline.

Our study has some limitations. The small number of patients with concomitant diseases associated with increased risk of melanoma is not enough to draw definite conclusions about an eventual association of HN with melanoma development and/or the prognostic significance for melanoma progression. However, all patients with pigmented skin lesions, regardless of whether they display HN, should undergo a routine full-body examination.12-15

Furthermore, the retrospective study design did not allow us to exactly define the date of onset in patients with HN who were followed up. Given that the waiting time for consultation at our clinic is approximately 2 months, we assumed that onset of HN occurred no longer than 3 months before baseline examination was performed. Accordingly, our observation of more rapid change in size during the first 6 months of follow-up must be seen in light of a speculative assumption of the time of HN development in a given individual. Finally, it must be underlined that we observed only 2 melanomas that displayed an encircling halo, but in both cases clear-cut melanoma-specific features were observed.

In summary, our study indicates that HN are common, although not exclusive, in children and young adults and display the typical dermoscopic features of benign melanocytic nevi, represented by variations on the globular pattern. The role and diagnostic impact of digital dermoscopic follow-up of HN in these patients, however, seem questionable. By contrast, halo melanoma is rare but reveals evident melanoma-specific patterns according to dermoscopy.

Correspondence: Rainer Hofmann-Wellenhof, MD, Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria (rainer.hofmann@meduni-graz.at).

Financial Disclosure: None reported.

Back to top

Article Information

Accepted for Publication: April 22, 2006.

Author Contributions:Study concept and design: Hofmann-Wellenhof, Kerl, and Zalaudek. Acquisition of data: Kolm, Di Stefani, Hofmann-Wellenhof, Fink-Puches, Wolf, and Richtig. Analysis and interpretation of data: Kolm, Di Stefani, Hofmann-Wellenhof, Smolle, and Soyer. Drafting of the manuscript: Kolm, Hofmann-Wellenhof, Fink-Puches, Wolf, Richtig, and Smolle. Critical revision of the manuscript for important intellectual content: Di Stefani, Hofmann-Wellenhof, Kerl, Soyer, and Zalaudek. Administrative, technical, and material support: Kolm, Hofmann-Wellenhof, Wolf, and Zalaudek. Study supervision: Di Stefani, Hofmann-Wellenhof, Fink-Puches, and Soyer.

References

1.

Sutton RLAn unusual variety of vitiligo (leucoderma acquisitum centrifugum).J Cutan Dis 1916;34797-800Google Scholar

2.

Kopf AWMorril SDSilberberg IBroad spectrum of leukoderma acquisitum centrifugum.Arch Dermatol 1965;9214-35PubMedGoogle ScholarCrossref

3.

MacKie RMDisorders of the cutaneous melanocyte: halo naevus.Burns TBreathnach SCox NGriffith Ceds.Rook's Textbook of Dermatology.27th ed. Oxford, England Blackwell Scientific Publications2004;1-39

4.

Fritsch PDermatologie und Venerologie. Grundlagen, Klinik und Atlas.2nd ed. Berlin, Germany Springer2004;627

5.

Herd RMHunter JAFamilial halo naevi.Clin Exp Dermatol 1998;2368-69PubMedGoogle ScholarCrossref

6.

Kerr OASchlofield OHalo congenital nevi.Pediatr Dermatol 2003;20541-542PubMedGoogle ScholarCrossref

7.

Mooney MABarr RJBuxton MGHalo nevus or halo phenomenon? a study of 142 cases.J Cutan Pathol 1995;22342-348PubMedGoogle ScholarCrossref

8.

Akasu RFrom LKahn HJCharacterization of the mononuclear infiltrate involved in regression of halo nevi.J Cutan Pathol 1994;21302-311PubMedGoogle ScholarCrossref

9.

Harvell JDMeehan SALeBoit PESpitz’s nevi with halo reaction: a histopathologic study of 17 cases.J Cutan Pathol 1997;24611-619PubMedGoogle ScholarCrossref

10.

Zeff RAFreitag AGrin CMGrant-Kels JMThe immune response in halo nevi.J Am Acad Dermatol 1997;37620-624PubMedGoogle ScholarCrossref

11.

Koh HKSober AJNakagawa H et al.Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study.J Am Acad Dermatol 1983;9696-708PubMedGoogle ScholarCrossref

12.

Fishman HCMalignant melanoma arising with two halo nevi.Arch Dermatol 1976;112407-408PubMedGoogle ScholarCrossref

13.

Pantoja EWendth AJBeecher TSPerilesional vitiligo in melanoma.Cutis 1977;1951-53PubMedGoogle Scholar

14.

Whimster IWThe halo naevus and cutaneous malignant melanoma.Br J Dermatol 1974;90111-113PubMedGoogle ScholarCrossref

15.

Inamadar ACPalit AAthanikar SB et al.Unusual course of a halo nevus.Pediatr Dermatol 2003;20542-543PubMedGoogle ScholarCrossref

16.

Kittler HPehamberger HWolff KBinder MDiagnostic accuracy of dermoscopy.Lancet Oncol 2002;3159-165PubMedGoogle ScholarCrossref

17.

Argenziano GSoyer HPChimenti S et al.Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.J Am Acad Dermatol 2003;48679-693PubMedGoogle ScholarCrossref

18.

Hofmann-Wellenhof RBlum AWolf IH et al.Dermoscopic classification of atypical melanocytic nevi (Clark nevi).Arch Dermatol 2001;1371575-1580PubMedGoogle ScholarCrossref

19.

Teban LPehamberger HWolff K et al.Klinische Wertigkeit einer dermatoskopischen Klassifikation von Clark-Nävi.J Dtsch Dermatol Ges 2003;1292-296PubMedGoogle ScholarCrossref

20.

Zalaudek IGrinschgl SArgenziano G et al.Age-related prevalence of dermoscopy patterns in acquired melanocytic nevi.Br J Dermatol 2006;154299-304PubMedGoogle ScholarCrossref

21.

Menzies SWGutenev AAvramidis MBatrac AMcCarthy WHShort-term digital surface microscopic monitoring of atypical or changing melanocytic lesions.Arch Dermatol 2001;1371583-1589PubMedGoogle ScholarCrossref

22.

Kittler HSeltenheim MDawid MPehamberger HWolff KBinder MFrequency and characteristics of enlarging common melanocytic nevi.Arch Dermatol 2000;136316-320PubMedGoogle ScholarCrossref

23.

Kittler HPehamberger HWolff KBinder MFollow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.J Am Acad Dermatol 2000;43467-476PubMedGoogle ScholarCrossref

24.

Kittler HBinder MFollow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits.Arch Dermatol 2002;1381379PubMedGoogle ScholarCrossref

25.

Skvara HTeban LFiebiger MBinder MKittler HLimitations of dermoscopy in the recognition of melanoma.Arch Dermatol 2005;141155-160PubMedGoogle ScholarCrossref

26.

Zalaudek IArgenziano GFerrara G et al.Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study.Br J Dermatol 2004;15064-71PubMedGoogle ScholarCrossref

Dermoscopy Patterns of Halo Nevi (2024)

FAQs

What are the 4 stages of halo nevus? ›

A halo naevus undergoes four stages:
  • Stage 1 - a rim of pale skin surrounds the mole.
  • Stage 2 - the mole starts to lighten or turn pink and eventually fades away.
  • Stage 3 - a circular or oval white area persists.
  • Stage 4 - the affected skin gradually returns to its normal colour.
Dec 14, 2023

Which subtype of nevus is most likely to develop a halo? ›

A halo nevus (HN) is usually an acquired melanocytic nevus, which can be a junctional, dermal, or compound nevus, surrounded by a white depigmented circle. Congenital nevi may also present a halo phenomenon. During its clinical course, an HN may progress up to complete clearing of the nevus.

Is halo nevus normal? ›

Halo naevi (US plural, nevi) are not uncommon, with an estimated prevalence of 1% of the white-skinned population. They are usually seen in healthy children or young adults of either sex.

Can a halo nevus be cancerous? ›

Can they be cancerous? Halo nevi are almost always benign. In rare cases, however, a halo nevus can indicate the presence of melanoma, a form of skin cancer, somewhere else on the body. This is more likely to be the case in older adults and those with halo nevi that are irregularly shaped or colored.

How long does a halo nevus last? ›

Observations have showed that the halo nevi last for 10 years or more, but a large subgroup passes through various stages to finally regress completely. The process takes approximately 8 years on average.

Which type of nevus is most likely to become malignant? ›

However, dysplastic nevi are a risk factor for developing melanoma, and the more dysplastic nevi a person has, the greater their risk of developing melanoma (1, 3). Researchers estimate that the risk of melanoma is about 10 times greater for someone with more than five dysplastic nevi than for someone who has none.

Is halo nevus an autoimmune disease? ›

The etiology of halo nevi is unknown. It is an autoimmune response and T lymphocytes are considered to play a key role in the progressive destruction of nevus cells.

How to treat halo nevus? ›

Medical Care. Halo nevi are benign, and no treatment is necessary.

Should I be worried about a halo mole? ›

If one has a halo mole, have a dermatologist to check it. Halos can be seen as part of a more generalized pigment loss as in vitiligo. Apart from an explanation and monitoring, no treatment is normally required. However sunscreen should be applied to all the skin during summer to prevent sunburn.

What is halo nevus also known as? ›

Halo nevus (also known as "Leukoderma acquisitum centrifugum," "Perinevoid vitiligo," and "Sutton nevus" ) is a mole that is surrounded by a depigmented ring or 'halo'.

Is halo nevus a form of vitiligo? ›

Halo nevi (HN) are acquired melanocytic nevi circumferentially surrounded by a depigmented patch. HN are commonly associated with vitiligo and can be associated with uveal, mucosal, or cutaneous melanoma in certain patient populations. HN may also have localized leukotrichia of terminal hair overlying the nevus.

When should I be worried about nevus? ›

If they do change in any way (in color, shape, size, border, etc.), or if you develop a sore that does not heal, you should see a dermatologist. Also have your dermatologist examine any new moles that you think are suspicious.

What are the warning signs of a halo nevus? ›

While benign halo nevi can be a cosmetic concern, it is important to pay attention to any changes in these lesions, just as you would with any mole. Changes in the shape, color, size or any bleeding, itching or irritation of a mole on the skin can be a warning sign for skin cancer.

What is the chance of a nevus turning into melanoma? ›

However, the risk of a single nevus progressing to melanoma is very low (less than 0.0005% annual risk), so most nevi will remain stable and not transform into melanoma [4].

Can you remove a halo mole? ›

A halo nevus does not require treatment, unless removal is desired for cosmetic reasons. A halo nevus does not require treatment, unless removal is desired for cosmetic reasons. However, a thorough screening for melanoma or family history of melanoma is recommended*.

Should halo moles be removed? ›

If one has a halo mole, have a dermatologist to check it. Halos can be seen as part of a more generalized pigment loss as in vitiligo. Apart from an explanation and monitoring, no treatment is normally required. However sunscreen should be applied to all the skin during summer to prevent sunburn.

When to biopsy halo nevus? ›

Physical Examination

However, individuals tend to have similar appearing nevi that are generally uniform in color, surface, and border. The pigmented lesion that differs from other nevi – the “ugly duckling” – should be biopsied to rule out malignant melanoma.

What is the life cycle of a nevus? ›

Benign melanocytic lesions follow an archetypal life cycle that consists of four stages: initiation, promotion, senescence, and involution. Initiation occurs when a nevus progenitor cell acquires a mutation that will permit future growth.

Top Articles
Latest Posts
Article information

Author: Patricia Veum II

Last Updated:

Views: 5618

Rating: 4.3 / 5 (44 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.